The review copy, and what it adds up to
There are no customer reviews on this site. What follows was supplied with the product; it is published as that, checked, and marked up as a review nowhere.
Read this first
This site publishes no customer reviews, collects none, and emits no Review or AggregateRating structured data on any page.
Review figures and eight named testimonial lines arrived in the written pack supplied with this product. They appear below because a buyer will meet them on the sales page and deserves to see what they come to.
Eight named lines carry two distinct sentences between them.
The audit
The distribution as supplied
- 5★66%
- 4★21%
- 3★8%
- 2★3%
- 1★2%
The eight lines, by how often each repeats
- 5 of 8
Fair at a month. Wanted more in week one.
- 3 of 8
Daily habit stuck. Reordered before the last bottle.
Two sentences, eight names, eight cities and eight ages.
| Check | What was supplied | What it comes to |
|---|---|---|
| The average against its own distribution | 4.6 out of 5, from 66/21/8/3/2 per cent | Those percentages average 4.46, which rounds to 4.5. The published figure is 4.6. |
| Written reviews against orders | 754 written, 7,982 orders | 9.4% of orders left a written review. |
| Recommend against the stars | 90% recommend | 5★ and 4★ together are 87%. |
| The eight published lines | 8 named buyers | They carry 2 distinct sentences between them. One appears five times, the other three. |
| How long they waited | “most wait 3–6 weeks”; the longest line is day 56 | The sales page for the same product says to give it 180 to 210 days. The two answers differ by a factor of four to ten. |
The FTC’s guidance for this industry is that “testimonials that report results more dramatic than users can generally expect are likely to be deceptive”, and that randomised controlled human trials are the evidence experts would require for a health-benefit claim. Two sentences under eight names are not evidence in either direction.
The eight lines, as supplied
Printed in full, attributed exactly as supplied, and presented as layout copy rather than as reviews.
| Name as supplied | Age | Place | Stars | Pack | Day | Line |
|---|---|---|---|---|---|---|
| Frank S. | 58 | Sacramento CA | 4★ | 2 | 56 | Fair at a month. Wanted more in week one. |
| Chris L. | 66 | Charlotte NC | 4★ | 6 | 45 | Fair at a month. Wanted more in week one. |
| Mark P. | 48 | Dallas TX | 5★ | 6 | 29 | Daily habit stuck. Reordered before the last bottle. |
| Neil R. | 48 | San Antonio TX | 3★ | 6 | 34 | Fair at a month. Wanted more in week one. |
| Derek W. | 48 | Phoenix AZ | 5★ | 2 | 35 | Daily habit stuck. Reordered before the last bottle. |
| William T. | 52 | Kansas City MO | 4★ | 2 | 26 | Fair at a month. Wanted more in week one. |
| David F. | 67 | Columbus OH | 5★ | 6 | 56 | Daily habit stuck. Reordered before the last bottle. |
| Leon W. | 48 | Indianapolis IN | 3★ | 3 | 41 | Fair at a month. Wanted more in week one. |
The waiting time does not match
| Where it comes from | What it says | In days |
|---|---|---|
| The sales page | give it 180 to 210 days to judge | 180–210 |
| The supplied review copy | most buyers wait 3 to 6 weeks | 21–42 |
| The eight supplied testimonials | the longest is day 56 | 26–56 |
| The guarantee | 180 days from purchase | 180 |
The review copy and the sales page were supplied in the same pack, for the same product, and they differ by a factor of four to ten on the one question a buyer most wants answered.
What the FTC asks of testimonials
The FTC's guidance for this industry is that testimonials that report results more dramatic than users can generally expect are likely to be deceptive
, that a results not typical
disclaimer does not cure a deceptive impression, and that randomised controlled human trials are the most reliable form of evidence
for a health-benefit claim.
Two sentences under eight names are not evidence in either direction. They are a reason to go and read the panel.
Our score instead
The Hawaiianzharmony editorial desk, 24 September 2026
- Label completeness3.5
The panel carries what FDA's guide asks for: serving size, servings per container, calories, the declared nutrient with its amount and %DV, the blend with its total weight, all four footnotes, the inactive list, a caution, storage and a distributor. It also carries extract ratios, which many labels do not.
- Dose transparency0.5
99.95% of the declared weight is one line with twenty-one names. This is the least legible panel in this series to date.
- Evidence at a reachable dose0.5
Eleven of the twenty-one have a published daily amount in a source we opened. Not one is reachable at its own arithmetic ceiling. Ten have no published amount at all, and for one the monograph says so explicitly.
- Seller identification1.5
Four names, a PO box against two Manhattan addresses, and a support email at a fourth company. The one redeeming detail is that the bottle prints a phone number the sales pages do not.
- Price and refund clarity3.0
Three prices, internally consistent, and a 180-day window that is long by the standards of this category. Marked down because the seller's own judging period runs past its own refund window and no pack sold covers the far end of it.
- Claim consistency1.0
The bottle says blood sugar; the checkout says cognition; the keywords say diabetes. The written pack had to warn against mixing formulas.
- Review honesty1.0
Eight named testimonials carrying two sentences between them, a headline average that does not match its own distribution, and a stated waiting time four to ten times shorter than the sales page's own.
This is our score, not a customer rating and not an average of anything supplied with the product. It is the mean of the seven figures above, each argued for in the sentence beside it. No star rating from any other source appears anywhere on this site.
Sources
- Health Products Compliance GuidanceU.S. Federal Trade Commission“Testimonials that report results more dramatic than users can generally expect are likely to be deceptive”; randomised controlled human trials are “the most reliable form of evidence” for health-benefit claims.
- FDA 101: Dietary SupplementsU.S. Food and Drug Administration“The FDA does NOT have the authority to approve dietary supplements for safety and effectiveness, or to approve their labeling, before the supplements are sold to the public”; a product intended to treat, prevent or cure a disease is a drug, whatever it is labelled.